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Reversible Reprogramming of Circulating Memory T
Follicular Helper Cell Function during Chronic HIV Infection
Rafael Cubas,* Julien van Grevenynghe,† Saintedym Wills,‡ Lela Kardava,x
Brian H. Santich,x Clarisa M. Buckner,x Roshell Muir,* Virginie Tardif,*
Carmen Nichols,* Francesco Procopio,{ Zhong He,* Talibah Metcalf,* Khader Ghneim,*
Michela Locci,‖ Petronella Ancuta,#,** Jean-Pierre Routy,††,‡‡,xx Lydie Trautmann,*
Yuxing Li,{{,‖‖ Adrian B. McDermott,## Rick A. Koup,## Constantinos Petrovas,##
Steven A. Migueles,*** Mark Connors,*** Georgia D. Tomaras,‡ Susan Moir,x
Shane Crotty,‖,†††,‡‡‡ and Elias K. Haddad*
Despite the overwhelming benefits of antiretroviral therapy (ART) in curtailing viral load in HIV-infected individuals, ART does not fully
restore cellular and humoral immunity. HIV-infected individuals under ART show reduced responses to vaccination and infections and are
unable to mount an effective antiviral immune response upon ART cessation. Many factors contribute to these defects, including persistent
inflammation, especially in lymphoid tissues, where T follicular helper (Tfh) cells instruct and help B cells launch an effective humoral immune
response. In this study we investigated the phenotype and function of circulating memory Tfh cells as a surrogate of Tfh cells in lymph nodes
and found significant impairment of this cell population in chronicallyHIV-infected individuals, leading to reducedB cell responses.We further
show that these aberrant memory Tfh cells exhibit an IL-2–responsive gene signature and are more polarized toward a Th1 phenotype.
Treatment of functional memory Tfh cells with IL-2 was able to recapitulate the detrimental reprogramming. Importantly, this defect was
reversible, as interfering with the IL-2 signaling pathway helped reverse the abnormal differentiation and improved Ab responses. Thus,
reversible reprogramming of memory Tfh cells in HIV-infected individuals could be used to enhance Ab responses. Altered microenviron-
mental conditions in lymphoid tissues leading to altered Tfh cell differentiation could provide one explanation for the poor responsiveness of
HIV-infected individuals to new Ags. This explanation has important implications for the development of therapeutic interventions to
enhance HIV- and vaccine-mediated Ab responses in patients under ART. The Journal of Immunology, 2015, 195: 5625–5636.
T
follicular helper (Tfh) cells are a specialized subset of
CD4+ T cells that provide help to B cells in germinal
centers (GCs) and instruct B cell differentiation into
affinity-matured, long-lived memory B cells and plasma cells (1). Tfh
cells deliver critical signals to GC B cells via costimulatory mole-
cules and lymphokine secretion and induce somatic hypermutation
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on Ag-specific B cells (1, 2). The differentiation of Tfh cells in-
volves multiple signals that lead to the activation of various tran-
scription factors, with the core programming being largely mediated
by Bcl6, Maf, STAT3, and STAT4 transcription factors (3). IL-2 is a
potent inhibitor of Tfh cell differentiation, as it interferes with
Bcl6 and CXCR5 expression (4–6) and is dose limiting for Th1
versus Tfh cell differentiation (4). In humans, administration of
IL-2 in vivo did not yield any clinical benefits to HIV-infected
subjects. However, PBMCs obtained from IL-2–treated patients
showed increased in CD25 expression and production of inflam-
matory cytokines (7, 8).
During HIV infection, vast cytokine imbalances (9) in lymphoid
tissues can persist despite antiretroviral therapy (ART), affecting
both T cell and B cell homeostasis (10). It has recently been
shown that HIV continues to undergo low-level replication in
lymphoid tissues, maintaining a state of immune activation in
individuals undergoing ART. In addition, B cell follicles appear to
represent protected niches where viral replication can persist de-
spite the presence of strong antiviral CD8+ T cell responses (11). It
is therefore conceivable that persistent inflammatory signals could
skew the differentiation profile of Tfh cells, leading to an altered
polarization and adoption of cytokine signaling programs, which
could affect their ability to provide adequate B cell help. The
lymph node (LN) microenvironment is likely responsible for in-
ducing major changes on Tfh cell function. As evidence for this,
we have previously shown that despite an increase in the frequency
of Tfh cells, their function is impaired in LNs from HIV-infected
individuals (12).
Recently, a population of blood circulating Tfh (cTfh) cells has
been described that represents a circulating memory counterpart of
LN-resident Tfh cells (13–15). If cTfh cells arise from Tfh cell
precursors in LNs, changes in the LN microenvironment could
imprint particular effector fates or functional skewing during their
differentiation into memory cells. With the difficulty of obtaining
LN samples, investigating the functional status of memory Tfh
cells in peripheral blood could provide a glimpse into the mi-
croenvironmental changes that took place in LNs during the dif-
ferentiation of these cells into memory counterparts. With the
recent demonstration that HIV continues to undergo low-level
replication in lymphoid tissues maintaining a state of immune
activation despite ART (16), it is conceivable that Tfh cells en-
counter environmental signals, which could affect their differen-
tiation and phenotype when transitioning into memory Tfh cells.
In this article, we show that memory Tfh cells from peripheral
blood of chronic aviremic (CA) individuals are functionally im-
paired in their ability to provide adequate B cell help when
compared with those from elite controllers (ECs). This impairment
stems in part from increased IL-2 signaling, which can affect the
differentiation and function of memory Tfh cells. We further dem-
onstrate that memory Tfh cells in CA individuals are more polarized
toward a Th1 phenotype with increased levels of Tbet expression;
increased secretion of IFN-g; and reduced expression of Bcl6,
CXCR5, and IL-21. Importantly, memory Tfh cells from CA subjects
are reprogrammable and still show plasticity, as their function can be
restored at least partly by interfering with IL-2 signaling.
Materials and Methods
Human samples
All procedures were approved by the Institutional Review Boards at the
relevant institutions, and all participants provided signed informed consent.
Frozen PBMCs were obtained from CA individuals and ECs who were
recruited from the Clinical Research Center, National Institutes of Health
(NIH). Patient information can be found in Tables I and II. PBMCs from
CA individuals and ECs were also obtained from patients who partici-
pated in the blood banking study from the Chronic Viral Illness Service at
McGill University Health Centre. Informed consent was signed by each
participant, and the study was approved by the Research Ethics Board of
Table I. Patient information on the CA-treated individuals used in various assays
Patient ID Age Diagnosis Year
CD4+ T Cell Count
(cells/mm3)
CD8+ T Cell Count
(cells/mm3)
Plasma HIV RNA
(copies/ml) ART Duration (y)
CA1 26 2000 611 509 ,50 9
CA2 53 1992 434 583 ,50 13
CA3 29 2001 702 586 ,50 8
CA4 39 1994 411 368 ,50 12
CA5 55 1985 657 1088 ,50 16
CA6 35 2003 517 259 ,50 6
CA7 47 NA 269 282 ,50 NA
CA8 50 2002 569 462 ,50 8
CA9 46 1998 391 620 ,50 14
CA10 49 2004 309 980 ,50 8
CA11 57 1986 670 1006 ,50 NA
CA12 59 1996 466 1329 ,50 9
CA13 46 1995 1079 324 ,50 13
CA14 43 1993 696 768 ,50 7
CA15 35 2001 500 625 ,50 5
CA16 43 1986 698 769 ,50 8
CA17 21 1992 850 648 ,50 7
CA18 41 1994 478 669 ,50 6
CA19 55 1986 276 414 ,50 9
CA20 33 2002 773 634 ,50 3
CA21 55 1986 750 1379 ,50 9
CA22 53 1985 333 1018 ,50 26
CA23 46 2000 530 1280 ,50 5
CA24 55 1995 536 676 ,50 18
CA25 32 1995 613 302 ,50 17
CA26 52 2000 785 1194 ,50 14
CA27 45 1999 572 829 ,50 15
CA28 24 1992 623 657 ,50 6
CA29 53 1997 932 1134 ,50 17
HIV-infected CA individuals were assessed for CD4 and CD8 counts as well as virus load.
NA, not available.
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the Research Institute of McGill University Health Centre. Blood samples
from healthy donors were obtained from Martin Memorial Health Systems.
PBMCs were isolated from blood by density-gradient centrifugation using
Ficoll-Paque PLUS (GE Healthcare). Cells were subsequently frozen and
used for the relevant assays. Fresh human tonsils were obtained from
tonsillectomies performed at Martin Memorial Health Systems. Tonsils
were processed as previously described (10).
Abs
The following fluorochrome-conjugated Abs were used: anti–human CD3
(clone UCHT1, 1:200), anti–human CD4 (clone RPA-T4, 1:200), anti–
human CD19 (clone HIB19, 1:100), anti–human CD27 (clone O323,
1:100), anti–human CD38 (clone HIT2, 1:100), anti–human CD95 (clone
DX2, 1:100), anti–human ICOS (clone C398.4A, 1:100), anti–human
CD40L (clone 24-31, 1:10), anti–human PD-1 (clone EH12.2H7, 1:100),
anti–human CXCR3 (clone G025H7, 1:200), anti–human CTLA4 (clone
L3D10, 1:10), anti–human CD69 (clone FN50, 1:50), and anti–human
IL-7Ra (clone A019D5, 1:100) were all from BioLegend. Anti–human
CXCR5 (clone RF8 B2, 1:200), anti–human Bcl-6 (clone K112-91, 1:20),
anti–human IgD (clone IA6-2, 1:50), anti–human Ki-67 (MOPC-21, 1:10),
and anti–human CD21 (clone B-ly4, 1:100) were from BD Biosciences,
and anti–human CD45RA (clone 2H4LDH11LDB9, 1:200) was from
Beckman Coulter. LIVE/DEAD Fixable Dead Cell Stain from Invitrogen
was used to gate on live cells as well as Annexin V from BD Biosciences.
Coculture assays
The cTfh cells defined as (CD3+CD4+CD45RA2CXCR5+CXCR32) or
the non-cTfh cells defined as (CD3+CD4+CD45RA2CXCR5+CXCR3+ or
CD3+CD4+CD45RA2CXCR52) were sorted and placed in coculture with
memory B cells (CD32CD19+CD27+) at equal numbers (1 3 104 cells
each) in the presence of 100 ng/ml staphylococcal enterotoxin B (SEB)
(Toxin Technology) in complete RPMI 1640 medium (Life Technologies).
Supernatants and cells were harvested at 3, 5, or 7 d for subsequent
analysis. SEB was added at the onset of the cocultures to mimic the in-
teraction between T cells and B cells in a polyclonal setting (13). The
presence of SEB was required to induce T cell activation and subsequent
T/B cell crosstalk (Supplemental Fig. 2C). Of note, SEB did not activate
memory B cells when cultured alone (Supplemental Fig. 2C, 2G). The
absolute number of cells was calculated using Flow-Count Fluorospheres
(Beckman Coulter) and following the manufacturer’s instructions. To sort
CFSElo/hi cells from the coculture, total PBMCs were first stained with
1.25 mM CFSE, followed by thorough washing. Cells were then sorted
and placed in coculture, as above. After either 24 h or 5 d, cells were
sorted for BioMark analysis. Alternatively, cells were kept for 7 d in
coculture followed by flow cytometry analysis.
ELISA
ELISAs were performed as previously described (10). In brief, for analysis
of total IgG output from the cocultures, 96-well Immulon 2HB plates
(Thermo Scientific) were coated overnight at 4˚C with monoclonal anti–
human IgG (Mabtech; clone MT91/145) at a concentration of 1 mg ml–1 in
PBS. The following day, plates were washed five times with PBS + 0.05%
Tween 20. Plates were subsequently blocked for 1 h with PBS + 10% FBS
at room temperature (RT). Plates were subsequently washed and the culture
supernatants added at different dilutions for 1 h at RT. After washing, the
plates were incubated with 1 mg ml–1 of anti–human IgG–biotin (Mabtech;
clone MT78/145) for 1 h at RT. The plates were then washed as above and
incubated with streptavidin-HRP (Mabtech) for 45 min at RT. Plates were
thoroughly washed, and 100 ml tetramethylbenzidine substrate (Sigma-
Aldrich) was added until the appearance of color. The enzymatic reac-
tion was stopped by the addition of 50 ml 1 M H3PO4. The OD (450 nM)
was then measured using a SpectraMax plus 384-plate reader (Molecular
Devices).
To detect Env-specific Ab responses, 96-well, high-binding, half-area
ELISA plates (Greiner Bio-One) were coated overnight at 4˚C with
1 mg ml–1 recombinant HIV-1 envelope protein (ProSpec) in PBS. The
following day, plates were washed five times with PBS + 0.05% Tween
20 and blocked for 1 h with PBS + 10% FBS at RT. Plates were subse-
quently washed and the culture supernatants added at different dilutions for
2 h at RT. For the standard curve, human HIV Ig was used. This reagent
was obtained through the NIH AIDS Research and Reference Reagent
Program, Division of AIDS, National Institute of Allergy and Infectious
Diseases, NIH (cat. no. 3957) from Dr. Luiz Barbosa, National Heart Lung
and Blood Institute. The plates were then washed and incubated with 1 mg
ml–1 anti–human IgG-biotin (Mabtech; clone MT78/145) for 1 h at RT,
followed by washing and incubation with streptavidin-HRP (Mabtech) for
45 min at RT. Plates were then thoroughly washed, and 50 ml tetrame-
thylbenzidine substrate (Sigma-Aldrich) was added until the appearance of
color. The enzymatic reaction was stopped by the addition of 25 ml 1 M
H3PO4. The OD (450 nM) was then measured using a SpectraMax plus
384-plate reader (Molecular Devices).
BioMark
Assays (Primers and Probes) were designed using the Roche Universal
Probe Library Assay Design Center (www.universalprobelibrary.com) and
were designed to detect multiple transcripts, without respect to isoform
prevalence. Cells were sorted directly into PCR plates and immediately
frozen. RNA extraction and PCR amplifications were done according to
manufacturer recommendations and as we have previously published (17).
Evaluation of Ag-specific B cells by flow cytometry
Mature B cells were stained with Abs against B cell markers, as well as
fluorochrome-conjugated probes derived from HIV YU2 gp140 and in-
fluenza H1N1 HA, as previously described (18). HIV-specific memory
B cells were identified using a trimeric HIV envelope gp140 probe. This
probe contains a site-specific biotinylation motif Avi tag at the C termini
that can be fluorescently labeled. The HIV-gp140 probe was conjugated
with streptavidin-allophycocyanin (Invitrogen). FACS analyses were
Table II. Patient information on the ECs used in various assays
Patient ID Age Diagnosis Year
CD4+ T Cell Count
(cells/mm3)
CD8+ T Cell Count
(cells/mm3)
Plasma HIV RNA
(copies/ml)
EC01 48 NA 788 2498 ,50
EC02 36 1999 711 574 ,50
EC03 54 1995 711 574 ,50
EC05 37 1994 641 1759 121
EC06 47 1991 611 583 ,50
EC07 43 NA 613 246 ,50
EC08 44 1989 913 519 ,50
EC09 40 1992 1116 708 ,50
EC10 50 1985 673 833 ,50
EC11 47 2004 679 556 ,50
EC12 57 1985 1334 805 ,50
EC13 61 1988 833 975 ,50
EC14 50 1985 902 722 ,50
EC15 48 1985 618 588 ,50
EC16 44 1989 729 492 ,50
EC17 52 2007 1943 716 ,50
EC18 60 1994 749 638 ,50
EC19 52 1995 552 607 ,50
EC20 47 1997 712 260 ,50
HIV-infected ECs were assessed for CD4 and CD8 counts as well as virus load.
NA, not available.
The Journal of Immunology 5627
 at IN
STITU
T PA
STEU
R CIS-BIBLIO
TH
EQUE on August 9, 2016
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
performed using a FACSCanto II flow cytometer (BD Biosciences).
Data were analyzed using FlowJo software (TreeStar).
Statistical analysis
All data were presented as means 6SD. Comparison between cohorts
(healthy control [HC], EC, and CA) were performed using a two-tailed
Mann–Whitney U test. This analysis is optimal for clinical cohorts, as it
does not assume normal Gaussian distribution of the data. For statistical
analyses within the same group using autologous or allogeneic cocultures
(substitution of one cell type), we used paired, nonparametric Wilcoxon
matched-pairs signed rank tests. For statistical analyses within the same
group (i.e., comparison between Ab levels in cocultures from ECs with or
without supplementation of IL-2 or IFN-g) two-tailed paired t tests were
used. Prism 5.0 (GraphPad) was used to process all the statistical analyses.
Results
Memory Tfh cells from CA individuals are functionally
impaired
First, we characterized the frequency and phenotype of cTfh cells
in peripheral blood from a cohort of HC, EC, and CA subjects
(Tables I and II). Memory Tfh cells are Ag experienced (CD45RA2),
have mostly a central-memory phenotype (CCR7+CD27+), and
have stable expression of CXCR5. These cells have also been
characterized as lacking the chemokine receptor CXCR3 (13, 14,
19). Unlike their GC counterparts, memory Tfh cells express high
levels of IL-7Ra, critical for long-term survival, and have a resting
phenotype (CD692, Ki-672). The majority of memory Tfh cells
also lack CD38 and ICOS expression (Supplemental Fig. 1A–E),
but a proportion of them express PD-1 (Supplemental Fig. 1F), as
previously shown (14). When comparing the three patient groups,
we did not observe any significant difference in the frequency and
absolute number of cTfh cells (Supplemental Fig. 1G). In addition,
we did not detect any significant difference in the expression of
costimulatory (ICOS, CD40L), inhibitory (PD-1), or activation
(CD38) markers following stimulation with anti-CD3/CD28
(Supplemental Fig. 1H). These results suggest that under anti-CD3/
CD28 stimulation, at least for the markers studied, there are no
apparent differences in the phenotype of memory Tfh cells be-
tween HC, EC, and CA subjects. However, the functional aspects
of cTfh cells are better investigated in the context of B cell interaction
FIGURE 1. cTfh cells from CA individuals are functionally impaired in their ability to provide adequate B cell help. (A) PBMCs from HC subjects were
sorted into cTfh cells (CD3+CD4+CD45RA2CXCR5+CXCR32), non-cTfh cells (CD3+CD4+CD45RA2CXCR5+CXCR3+ and CD3+CD4+CD45RA2CXCR52),
and CD27+ memory B cells and placed in coculture for 7 d in the presence of SEB. Shown are the total levels of IgG in the coculture supernatants after 3, 5, and
7 d, as measured by ELISA. n = 4–12. (B and C) PBMCs from HC, EC, and CA subjects were also sorted into cTfh cells and memory B cells and placed in
coculture for 7 d in the presence of SEB. (B) Total levels of IgG after 7 d. (C) Absolute number of live B cells after 7 d. n = 16–24. (D–H) Alternatively, either
cTfh cells or memory B cells from a sorted pool of HCs were used to substitute cTfh cells or memory B cells in cocultures from EC or CA subjects. (D) Total
levels of IgG after replacing cTfh cells from CA subjects with cTfh cells from HCs. (E) Total levels of IgG after replacing cTfh cells from ECs with cTfh cells
from HCs. (F) Comparison of total IgG levels in cocultures from ECs with CA subjects with substituted cTfh cells from HCs. (G) Total IgG levels in cocultures
after replacing cTfh cells from ECs and CA subjects with cTfh cells from HCs. (H) Total IgG levels in cocultures after replacing memory B cells from ECs and
CA subjects with memory B cells from HCs. Bars represent mean 6 SD. (D–H) n = 8. Each dot represents the average of samples done in triplicate.
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and crosstalk. To accomplish this, we performed coculture assays
with sorted memory Tfh cells (defined as CXCR5+CXCR32 CD4+
memory T cells) and sorted memory B cells (defined as CD32CD19+
CD27+). As a control, we also cocultured non-Tfh cells (defined as
CXCR5+CXCR3+ or CXCR52 CD4+ memory T cells) with memory
B cells.
Similar to their GC counterparts, cTfh cells are specialized in
providing B cell help. This characteristic was evidenced by both Ab
output (Fig. 1A) and the absolute number of proliferating B cells
after 7 d in coculture (Supplemental Fig. 2A). CXCR3+ cells did
not provide adequate B cell help, despite having a similar pro-
liferative capacity to cTfh cells (Fig. 1A, Supplemental Fig. 2B),
corroborating previous findings (13). In addition, activation of
Tfh cells (using SEB) was required for their adequate function
(Supplemental Fig. 2C). The absolute number of live B cells in the
coculture was positively correlated with the total level of IgG
(data not shown), demonstrating a relationship between cTfh-
mediated B cell help and Ab production. From these results, it
is evident that cTfh cells defined as CXCR5+CXCR32 CD4+
memory T cells provide optimal help to memory B cells.
Using this coculture assay on 17 HC, 16 EC, and 24 CA in-
dividuals, we found that cocultures from CA subjects showed
significantly lower levels of total IgG Ab output when compared with
cocultures from ECs and HCs (Fig. 1B, p, 0.001). The differences in
IgG levels were not due to a decrease in the absolute number of live
B cells (Fig. 1C) or cTfh cells, as the absolute number of these cells
was comparable between EC and CA subjects (Supplemental Fig.
2D). This finding suggests that the blunted IgG Ab levels could be
due to defective cTfh/B cell interaction, which could influence
memory B cell differentiation into IgG-secreting cells. To inves-
tigate this possibility further, we determined if we could restore
Ab output by exchanging cTfh cells from CAs with cTfh cells
from HC subjects, while maintaining the same memory B cells
from CA individuals. Our results showed that replacing cTfh
cells from CA subjects with cTfh cells from HCs significantly in-
creased total IgG Ab output in cocultures with memory B cells from
CA subjects (Fig. 1D, p , 0.01). The restoration in Ab production
was not due to an allogeneic effect, as memory B cells cocultured
with allogeneic cTfh cells from HCs in the absence of stimulation
(SEB) did not secrete detectable levels of IgG and showed poor
viability (Supplemental Fig. 2G). Furthermore, in cocultures with
memory B cells from ECs, replacing cTfh cells from ECs with
cTfh cells from HCs did not enhance Ab production (Fig. 1E).
In addition, the mean fluorescence intensity (MFI) of CD27, a
FIGURE 2. Altered IL-2Ra and CXCR5 expression in cTfh cells from CA subjects. PBMCs from EC or CA subjects were sorted into cTfh cells and
memory B cells and placed in coculture. After 7 d, cTfh cells were resorted for quantitative real-time PCR analysis using the Fluidigm BioMark HD
System. Day 0 samples were used for normalization. (A) Fold change in the relative expression of genes, as assessed by real-time PCR analysis with respect
to measurements at day 0. Results from five EC and four CA subjects are shown. Each dot represents the average of two biological replicates with four to
six experimental replicates each. Bars represent mean 6SD. (B–F). PBMCs were sorted as above and placed in autologous cocultures for 7 d or alter-
natively placed in coculture with either cTfh cells or memory B cells from a sorted pool of HCs instead of their own autologous counterparts. (B) Frequency
of CD25 expression on cTfh cells from autologous cocultures or when these cells were replaced in cocultures from CA subjects with cTfh cells from HCs.
(C) CXCR5 MFI on cTfh. (D) Correlation between the frequency of CD25 expression and CXCR5 MFI on cTfh cells. (E) Correlation between CD25
expression on cTfh cells and total IgG Ab levels in the coculture. (F) Correlation between CXCR5 MFI on cTfh cells and IgG levels.
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marker highly expressed on Ab-secreting cells (ASCs), was sig-
nificantly reduced in cocultures from CA subjects but restored when
these cells were cultured with cTfh cells from HCs (Supplemental
Fig. 2E, 2F, p , 0.001). This observation suggests that memory
B cells from CA subjects have a reduced capacity to differentiate
into ASCs in the presence of impaired autologous cTfh cells.
For CA individuals, replacing autologous cTfh cells with those
from HCs restored Ab production to the levels observed in ECs
(Fig. 1F). This observation indicated that the memory B cell
compartment in CA subjects had a similar intrinsic capacity to
differentiate into ASCs when compared with ECs. This finding
was further corroborated by coculturing memory B cells from CAs
and ECs with cTfh cells from HCs, showing that memory B cells
from both EC and CA subjects produced similar quantities of IgG
(Fig. 1G).
The impairment in cTfh cell function in CA individuals became
more apparent when we cocultured memory B cells from HCs with
cTfh cells from either ECs or CA subjects. The results indicated
that total IgG Ab output with cTfh cells from CA individuals was
significantly decreased when compared with cocultures with cTfh
cells from ECs (Fig. 1H, p, 0.02). Together, these results suggest
that the reduced Ab production observed in cocultures from CA
subjects was primarily due to dysfunctional cTfh cells rather than
intrinsic memory B cell defects.
Memory Tfh cells from CA subjects show increased IL-2
signaling
To continue characterizing the cTfh cell defect in CA subjects, we
sorted cTfh cells after 7 d in coculture with memory B cells for
Fluidigm BioMark analysis and compared their transcriptional
gene fold change to sorted cTfh cells on day 0. We observed that
some cTfh cells from cocultures of CA subjects showed a tendency
toward increased IL-2Ra expression and lower levels of BCL6,
CXCR5 and IL21, canonical Tfh related genes essential for Tfh
cell differentiation, trafficking, and B cell help when compared
with cTfh cells from ECs (Fig. 2A). Even though the number of
samples used in this assay was limited, the results suggested possible
trends in the expression of some of these genes and made us pursue
these differences further at the protein levels. Thus, we investigated
expression of the high-affinity IL-2 receptor (IL-2Ra/CD25) at the
protein level in cocultures from CA individuals and ECs. We
observed a significant increase (p , 0.02) in the frequency of
CD25+ cTfh cells in cocultures from CA individuals, whereas the
expression levels of CXCR5 were significantly reduced (p ,
0.001) (Fig. 2B, 2C). The increase in CD25+ cTfh cells was not
due to signals coming from the memory B cells, as cocultures of
memory B cells from CA subjects with cTfh cells from HCs did
not result in an increase of CD25 expression on the cTfh cells
(Fig. 2B). This finding suggests that the increase in CD25 ex-
pression was due to intrinsic properties in the cTfh cell compart-
ment from CA individuals. In addition, we observed significant
negative correlations between CD25 expression on cTfh cells and
their expression level of CXCR5 and IgG Ab output in the co-
cultures (Fig. 2D, 2E, p, 0.001 and p, 0.01, respectively). On the
contrary, we observed a significant positive correlation between
CXCR5 MFI on cTfh cells and total IgG Ab levels (Fig. 2F, p ,
0.0001). Together, these results imply that cTfh cells from CA
subjects can display increased IL-2 signaling, which could be partly
responsible for reprogramming these cells and altering their polar-
ization and capacity to provide B cell help.
The expression of CD25 is regulated by TCR stimulation but
can be sustained by IL-2 in a positive feedback loop involving
STAT5 (20, 21). Indeed, we observed significantly higher levels of
IL-2 in cocultures from CA subjects (Fig. 3A, p, 0.01), and these
levels were significantly reduced when exchanging cTfh cells
from CA subjects with those from HCs. In addition, exchanging
the memory B cells did not affect the levels of IL-2 in cocultures
from CA subjects, indicating that the increased levels of IL-2 were
coming from the cTfh cells (Fig. 3A). Furthermore, we observed a
significant positive correlation between the levels of IL-2 and the
expression of CD25 on cTfh cells (Fig. 3B, p , 0.03). The in-
crease in IL-2 was also negatively correlated with total IgG Ab
output (Fig. 3C, p , 0.02). These results suggest that the re-
programming of cTfh cells during chronic HIV infection could be
partly the result of increased IL-2 signaling on these cells. A
similar increase in the levels of IL-2 was also observed in co-
culture of non-cTfh cells (CXCR5+CXCR3+) and memory B cells
when compared with cocultures from cTfh cells in HCs (Fig. 3D).
This observation suggests that the cTfh cells in CA subjects are
skewed toward a non-cTfh phenotype and increased IL-2 production.
FIGURE 3. cTfh cells from CA subjects show increased
IL-2 signaling. (A–C) PBMCs from EC or CA subjects were
sorted into cTfh cells and memory B cells and placed in
autologous cocultures for 7 d or alternatively placed in co-
culture with either cTfh cells or memory B cells from a
sorted pool of HCs instead of their own autologous coun-
terparts. All analyses were performed after 7 d in coculture.
(A) Levels of IL-2 in cocultures after 7 d. (B) Correlation
between the frequency of CD25 expression on cTfh cells and
IL-2 levels in the coculture. (C) Correlation between IL-2
and the total levels of IgG in the cocultures. cTfh (CXCR5+
CXCR32), non-cTfh (CXCR5+CXCR3+), and memory B
cells were also sorted from HC subjects and cocultured in
the presence of SEB. (D) Total levels of IL-2 in the coculture
supernatants after 7 d. Bars represent mean 6SD. n = 8 for
(A), n = 16 for (B) and (C), n = 5 for (D). Each dot represents
the average of samples done in triplicate.
5630 ALTERED MEMORY Tfh CELL FUNCTION IS REVERSIBLE DURING HIV
 at IN
STITU
T PA
STEU
R CIS-BIBLIO
TH
EQUE on August 9, 2016
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
Memory Tfh cells from CA individuals are more polarized
toward a Th1 phenotype
Triggering of IL-2R could activate downstream signals that could
interfere with the STAT3-Bcl6 axis, skewing the polarization of
memory Tfh cells. As evidence for this, we observed significantly
higher levels (p , 0.001) of the characteristic Th1 cytokine IFN-g
(22, 23) in cocultures from CA individuals. Similar to what we
observed for IL-2, the levels of IFN-g were also significantly re-
duced when cTfh cells from HCs were used in the cocultures
(Fig. 4A, p , 0.01). We also observed a significant negative
correlation between IFN-g and total IgG levels (Fig. 4B, p ,
0.001). Moreover, we observed a significant increase in TNF-a,
another characteristic Th1 cytokine in cocultures from CA sub-
jects (Fig. 4C, p , 0.001). As with IFN-g, the levels of TNF-a
were significantly reduced by exchanging with cTfh cells from
HCs (Fig. 4C, p , 0.01). Furthermore, a significant negative
correlation was found between the levels of TNF-a and total IgG
(Fig. 4D, p , 0.002). IL-2 showed a positive correlation with both
IFN-g (p , 0.01) and TNF-a (p , 0.0001), and TNF-a showed a
positive correlation (p , 0.0002) with IFN-g (Fig. 4E–G). In
addition, we also observed a similar increase in the levels of IFN-g
when coculturing non-cTfh cells (CXCR5+CXCR3+) with mem-
ory B cells in samples from HCs (Fig. 4H), suggesting that cTfh
cells in CA subjects appear to be more polarized toward a Th1
phenotype.
IL-2 can reprogram memory Tfh cell function
We then supplemented memory Tfh/B cell cocultures from ECs
with IL-2 or IFN-g to determine whether we could recapitulate the
functional defects observed with cTfh cells from CA subjects. As
shown in Fig. 5A and 5B, IL-2 supplementation led to a significant
decrease in total IgG Ab levels (p, 0.03), whereas IFN-g reduced
the levels of total IgG, but not to the same extent as observed with
IL-2 supplementation. The decrease in Ab output in the presence
of IL-2 was not due to differences in the absolute number of cTfh
cells, as their numbers were similar (in the case of IFN-g) or ele-
vated (in the case of IL-2) when compared with the controls
(Fig. 5C). Supplementation with IL-2 also increased the expres-
sion of CD25 (p , 0.01) on cTfh cells while decreasing CXCR5
expression (p , 0.001) (Fig. 5D, 5E). In addition, CD27 MFI was
significantly decreased on B cells, suggesting reduced differentiation
into ASCs (Fig. 5F, p , 0.01). Importantly, IL-2 supplementation
significantly increased the levels of the Th1 transcription factor Tbet
(Fig. 5G, p , 0.01) on cTfh cells as well as the transcription factor
FIGURE 4. cTfh cells from CA individuals are polarized toward a Th1 phenotype. (A–G) PBMCs from EC or CA subjects were sorted into cTfh cells
and memory B cells and placed in autologous cocultures for 7 d or alternatively placed in cocultures with either cTfh cells or memory B cells from a sorted
pool of HCs instead of their autologous counterparts. (A) IFN-g levels in the cocultures after 7 d. (B) Correlation between IFN-g and total IgG. (C) TNF-a
levels in the cocultures after 7 d. (D) Correlation between TNF-a and total IgG. (E) Correlation between IL-2 and IFN-g levels. (F) Correlation between
IL-2 and TNF-a levels. (G) Correlation between IFN-g and TNF-a levels. cTfh (CXCR5+CXCR32), non-cTfh (CXCR5+CXCR3+), and memory B cells
were also sorted from HCs and cocultured in the presence of SEB. (H) Total levels of IFN-g in the coculture supernatants after 7 d. n = 8 for (A) and (C), n =
16 for (B) and (D)–(G), n = 5 for (H). Each dot represents the average of samples done in triplicate.
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Blimp1, which antagonizes Bcl6 expression and Tfh cell differen-
tiation (Fig. 5H, p , 0.01) (24). We also observed a positive cor-
relation between Tbet and Blimp1 expression on these cells (Fig. 5I,
p , 0.02). Samples supplemented with IL-2 also showed increased
levels of IFN-g and TNF-a production (Supplemental Fig. 3A, 3B).
However, samples supplemented with IFN-g did not show an in-
crease in IL-2 production or TNF-a levels (Supplemental Fig. 3C,
3D), suggesting that increased IL-2 signaling might be an important
driver or maintainer of memory Tfh cell polarization toward a Th1-
like phenotype in CA subjects.
To determine whether the aberrant Th1 polarization on cTfh
cells from CA subjects could be reversed, we interfered with
IL-2 signaling in the coculture. This was achieved by adding a
titrated amount of aIL-2 Ab to the cocultures to reduce the
heightened levels of IL-2 without completely blocking signaling
through CD25, which is required for both cTfh and B cell survival
(data not shown). Reducing the levels of IL-2 in cocultures from
CA individuals led to an increase in total IgG Ab output (Fig. 6A,
p , 0.01) as well as decreased CD25 expression (Fig. 6B, p ,
0.01) and increased CXCR5 levels on cTfh cells (Fig. 6C, p ,
0.01). In addition, we observed a significant decrease in the ex-
pression of the transcription factor Tbet, which plays a major role
in driving Th1 differentiation (Fig. 6D, p , 0.01) as well as
Blimp1 (Fig. 6E, p , 0.02), which can block Bcl6 expression
and Tfh cell differentiation (24). Furthermore, increased Tbet
expression was significantly correlated (Fig. 6F, p , 0.01) with
decreased IgG levels as well as decreased CXCR5 expression on
cTfh cells (Fig. 6G, p , 0.0001). On the contrary, increased ex-
pression of Tbet on cTfh cells was significantly and positively
correlated with increased expression levels of CD25 (Fig. 6H, p ,
0.0001) and Blimp1 (Fig. 6I, p, 0.0001). Thus, the apparent Th1-
like programming of cTfh cells in CA subjects can be partly re-
versed by dampening IL-2 signaling, leading to a more functional
cTfh cell phenotype and an improved capacity to provide B cell
help.
HIV-specific Ab responses in CA subjects can be enhanced by
adequate cTfh cell help
We next determined whether we could enhance the production
of HIV-specific Abs by providing adequate B cell help. We first
determined whether HIV-specific memory B cells were present in
our cohort of CA subjects, as HIV-infected individuals under ART
show a continuous loss of HIV-specific memory B cells (17, 25–
28). We used a fluorochrome-labeled gp140 probe to detect Ag-
specific memory B cells by flow cytometry. We observed that, com-
pared with ECs, there was a significant reduction in the frequency of
FIGURE 5. IL-2 reprograms cTfh cells. (A–F) Cocultures of cTfh cells and memory B cells (1 3 104 each) from ECs were supplemented with either
10 ng/ml of IL-2 or 10 ng/ml of IFN-g. (A) Total levels of IgG in coculture supernatants from control samples and samples supplemented with exogenous
IL-2, as measured by ELISA after 7 d. (B) Total levels of IgG in the presence or absence of IFN-g. (C) Absolute number of live cTfh cells after 7 d. Bars
represent mean6SD. (D) Frequency of CD25 expression on cTfh cells after 7 d in coculture. (E) CXCR5 MFI on cTfh cells after 7 d in coculture. (F) CD27
MFI on B cells after 7 d. n = 5. Each dot represents the average of samples done in triplicate. (G) Fold change in the MFI of Tbet, as measured by in-
tracellular staining (ICS) in control and IL-2–supplemented cocultures after 7 d (n = 5). (H) Fold change in the MFI of Blimp1, as measured by ICS after 7 d
in coculture (n = 5). (I) Correlation between Tbet MFI and Blimp1 MFI, as measured by ICS in control and IL-2–supplemented cocultures after 7 d.
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gp140-specific memory B cells in CA individuals (Fig. 7A, p ,
0.001). We also observed a reduction in influenza-specific memory
B cells, although the difference did not reach statistical significance
(data not shown). We then measured HIV-specific Ab levels in co-
cultures from EC and CA subjects. As expected, we found signifi-
cantly lower levels of HIV-specific Abs in cocultures from CA
subjects, and the majority of these individuals did not have measur-
able HIV-specific Abs (Fig. 7B, p, 0.00001). This decrease in HIV-
specific responses from CA subjects was evident for Abs against
gp140 (p , 0.001) and gp41 (p , 0.001) and the predominant IgG
subclasses for anti-HIV responses: IgG1 (p , 0.01) and IgG3 (p ,
0.001) (Supplemental Fig. 4). Reduced production of IL-21 by cTfh
cells from CA subjects, as suggested by our BioMark data, could
partly explain the reduced levels of HIV-specific IgG1 and IgG3 (29).
Importantly, when we supplemented cocultures from ECs with IL-2
or IFN-g, we observed a significant reduction in HIV-specific Ab
levels (p , 0.001 and p , 0.02, respectively) that reached levels
similar to those observed in cocultures from CA subjects (Fig. 7C,
7D). However, when cTfh cells from CA individuals were replaced
in the cocultures for cTfh cells from HCs, the level of Env-specific
IgG was increased (Fig. 7E, p, 0.01). We also observed a significant
increase in the level of Env-specific IgG when cocultures from CA
subjects were supplemented with recombinant IL-21 (Fig. 7F, p ,
0.03). Thus, in the presence of functional cTfh cell help, Env-specific
IgG levels are enhanced in cocultures from CA subjects.
Discussion
In this study, we have shown that cTfh cells from CA individuals
are functionally impaired in their ability to provide adequate B cell
help when compared with memory Tfh cells from ECs and HCs.
Memory Tfh cells from CA subjects showed increased IL-2 sig-
naling as well as impaired differentiation and function. In accor-
dance, studies in mice have shown a negative role of IL-2 signaling
in mediating Tfh cell differentiation (4–6). Increased autocrine
IL-2 levels could be leading to heightened STAT5 signaling,
which has been shown to repress Bcl6 expression by upregulating
Blimp-1 (4, 6, 24, 30). In fact, we observed that increased IL-2
signaling significantly raised the levels of Blimp1 (Fig. 5H),
whereas interfering with IL-2 signaling reduced Blimp1 levels
(Fig. 6E). Constitutive STAT5 signaling can selectively block Tfh
cell differentiation and GC formation, and this has been shown to
be largely mediated by IL-2 signaling (4). However, the relationship
between phosphorylated STAT5 and STAT3 levels on these cells
still needs to be investigated. Nevertheless, IL-2 could be playing
an important role by antagonizing Tfh cell differentiation, and
signals through the IL-2R (CD25) could be contributing to shifting
FIGURE 6. Interfering with IL-2 signaling enhances cTfh cell differentiation and function in CA individuals. (A–E) Cocultures of sorted cTfh cells and
memory B cells (2 3 104 each) from CA individuals were supplemented with an isotype control or a titrated amount of anti–IL-2 Ab (100 ng/ml) on day
0 and day 3 to reduce the levels of IL-2 in the cocultures without completely inhibiting signaling through CD25. After 7 d, the supernatants and cells were
collected for further analysis. (A) Total levels of IgG in coculture supernatants from control samples and samples supplemented with an anti–IL-2 Ab, as
measured by ELISA after 7 d. (B) Frequency of CD25 expression on cTfh cells after 7 d in coculture. (C) CXCR5 MFI on cTfh cells after 7 d in coculture.
(D) Fold change in the MFI of Tbet and (E) Blimp1, as measured by intracellular staining (ICS) in control and anti–IL-2 Ab–treated cocultures after 7 d (n =
9). (F) Correlation between Tbet MFI and total IgG Ab output after 7 d. (G) Correlation between Tbet and CXCR5 expression levels, as measured by MFI.
(H) Correlation between Tbet and CD25 expression levels, as measured by MFI. (I) Correlation between Tbet and Blimp1 expression levels, as measured by MFI.
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the balance in favor of Th1–effector differentiation (4, 5, 31, 32).
Recent evidence also suggests that defects in the IL-2 pathway
leading to suboptimal IL-2 signaling could favor increased Tfh
cell differentiation in the setting of type 1 diabetes (33). Increased
autocrine IL-2 levels could therefore be affecting the differentia-
tion of Tfh cells and could be partly responsible for the altered
functional output in memory Tfh cells from CA subjects. In fact,
this Tfh cell defect could contribute to the impaired vaccine re-
sponses reported in HIV-infected individuals. For example, it has
been shown that the immune response to both hepatitis A and B
vaccines seems to be reduced in HIV-infected subjects (34). In
addition, the levels of Abs to tetanus toxoid and measles are
significantly lower in HIV-infected individuals (35), and (36).
Furthermore, it has been shown that some HIV-infected subjects
have poor responses to influenza vaccination (37).
However, it is important to note that this increase in IL-2 sig-
naling was not observed across all the CA samples studied and
additional factors might also be contributing to the skewing of
memory Tfh cell differentiation toward a Th1 phenotype. IFN-g
and TNF-a could also be playing a role in altering and main-
taining a Th1-like polarization in memory Tfh cells from CA
individuals as well as directly affecting B cell responses. We
observed increased levels of both of these cytokines in cocultures
from CA subjects as well as blunted B cell help in cocultures from
ECs following addition of IFN-g. The production of these cyto-
kines is likely the result of memory Tfh cell polarization toward a
Th1-like phenotype. IFN-g signaling leads to increased levels of
Tbet expression via induction of STAT1 (38). This activity could
help tilt the balance in favor of Tbet expression and away from
Bcl6. If the levels of Bcl6 go down, this would allow memory Tfh
cells to become more polarized toward other effector phenotypes
by allowing other transcription factors such as Tbet to outcompete
Bcl6 signaling. Indeed, we observed that memory Tfh cells from
CA subjects had increased Tbet expression as well as IFN-g and
TNF-a production, molecular targets of Tbet.
Our multiplex Fluidigm BioMark analysis also revealed de-
creased levels of the canonical Tfh cell cytokine IL-21 in cTfh
cells from cocultures of CA individuals when compared with ECs.
Indeed, blocking IL-21 signaling in cocultures from HC subjects,
using an IL-21R Fc chimera, significantly blunted Ab production
FIGURE 7. Decreased HIV-specific Ab responses in CA subjects can be enhanced by adequate cTfh cell help. Mature B cells from EC and CA in-
dividuals were stained ex vivo to quantify the frequency of gp140 (APC-gp140) or influenza-specific (PE-H1-CA09) memory B cells (see Materials and
Methods). (A) Frequency of gp140 binding as a percentage of IgG+ B cells. (B–E) PBMCs from HC, EC, or CA subjects were sorted into cTfh cells and
memory B cells and placed in coculture for 7 d. (B) Total levels of Env-specific IgG after 7 d. n = 11, 15, and 23 for HC, EC, and CA, respectively. (C) Fold
change in the levels of Env-specific IgG in cocultures from ECs in the presence or absence of 10 ng/ml of IL-2. n = 5. Also shown is the comparison
between the levels of Env-specific IgG in cocultures from ECs with IL-2 supplementation with respect to cocultures from CA subjects. (D) Fold change in
the levels of Env-specific IgG in cocultures from ECs in the presence or absence of 10 ng/ml of IFN-g. n = 5. Also shown is the comparison between the
levels of Env-specific IgG in cocultures from ECs with IFN-g supplementation with respect to cocultures from CA subjects. Bars represent mean 6SD. (E)
Total levels of Env-specific IgG in cocultures from CA subjects with autologous cTfh cells or with cTfh cells from HCs. n = 8. Each dot represents the
average of samples done in triplicate. (F) Total levels of Env-specific IgG, as measured by ELISA in cocultures from CA subjects after 7 d following
supplementation with IL-21 (10 ng/ml).
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and the absolute number of live B cells (Supplemental Fig. 3E).
Furthermore, supplementation of cocultures from CA subjects
with IL-21 significantly increased total IgG Ab output (Supplemental
Fig. 3E). The reduced expression of IL-21 in cTfh cells from CA
subjects could be partly the result of increased IL-2 signaling on
these cells, which could interfere with the STAT3-Bcl6 axis via
STAT5 induction, but the overall functional defect in these cells is
likely maintained by a combination of signals and altered tran-
scription factor balance. In this sense, increased IL-2 signaling
might be playing an important role in helping to interfere with
Bcl6 function, which, together with IFN-g and TNF-a, could
further help to drive the altered polarization of memory Tfh cells
into a Th1-like phenotype in CA subjects.
How these memory Tfh cells acquire a Th1-like phenotype upon
activation is unknown, but it is reasonable to speculate that
memory Tfh cells in HIV-infected individuals under ART may
continue to experience heightened levels of proinflammatory
signals in LNs that, despite ART, can maintain residual contin-
uous local inflammation (16) and viral replication (11). It has
been shown that the Tfh cell subset in LNs is a preferential target
for HIV infection (39). Because the phenotype of cTfh cells
encompasses resting memory T cells, which harbor viral DNA,
these cells could also contain viral DNA at extremely low fre-
quencies (one in a million cells) (40, 41). Thus, at this very low
frequency, it is possible that the polyclonal function of these
cells could not be compromised by viral infection. To confirm
this, we performed coculture assays in the presence or absence of
ART and found no significant difference in cell viability and Ab
production, suggesting that virus infection and replication, at low
levels, do not contribute to Tfh dysfunction (data not shown).
Furthermore, it is possible that increased Blimp1 expression and
IL-2R signaling could be driving these cells toward a regulatory
T cell phenotype (42). However, we did not observe a significant
frequency of FOXP3+ cTfh cells in cocultures from CA subjects
(data not shown), and the increased expression levels of IFN-g and
TNF-a suggest that these cells are not acquiring a T follicular
regulatory T cell/regulatory T cell–like phenotype.
It is also important to point out that in this study we investigated
only the phenotype and function of cTfh cells in peripheral blood
and not LN-resident Tfh cells, owing to the difficulty of obtaining
lymphoid tissues from HIV-infected individuals and HCs. It is still
unclear to what extent memory Tfh cells represent their LN coun-
terparts. Memory Tfh cells could generate from pre-Tfh cells before
these cells enter the GC or could be derived from GC Tfh cells.
However, the exact identity of these cells is still under investigation.
For this reason we cannot conclude that what we observe in cTfh
cells is exactly what is occurring to Tfh cells in LNs, but by in-
vestigating these cells we can infer what general microenvironmental
conditions were present in lymphoid tissues when these cells dif-
ferentiated. This understanding provides a glimpse into the condi-
tions experienced in LNs by both of these cell types, which could
affect their overall differentiation and polarization. Our findings
therefore provide an insight into the mechanisms responsible for
the induction and maintenance of Tfh cell differentiation that could
be important in vaccine development. Enhancing memory Tfh cell
function could also help overcome various humoral immune defects;
enhance Ab effector functions; and improve the affinity maturation
of HIV-specific Abs in HIV-infected individuals, which could po-
tentially lead to an improved control of viral replication.
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